AMPK lengthens the circadian clock period through NAD+-dependent regulation of Bmal1
Experiments in human cells and computational modeling show that fasting sensor AMPK requires NAD+ and PGC-1-alpha to modulate cellular circadian rhythms.
bioRxiv · Vandenberghe A et al. · Paper published 30 Sep 2026
In human U2OS cells, researchers examined how the fasting sensor AMP-dependent kinase (AMPK) regulates the circadian clock. The team used a Bmal1 promoter-driven luciferase reporter and mathematical simulations to monitor molecular clock activity. Pharmacological activation of AMPK with AICAR elevated Bmal1 promoter activity and lengthened the clock period in a dose-dependent manner. In contrast, inhibiting PGC-1-alpha with SR18292 shortened the clock period. Blocking nicotinamide phosphoribosyltransferase with FK866 abolished the effects of AICAR, showing that this AMPK-dependent regulation requires NAD+ availability. Numerical simulations and phase response curves matched the experimental data, confirming that metabolic signals can adjust the cellular clock through NAD+-dependent AMPK signaling.
Why it matters
Proper communication between metabolic sensors and circadian rhythms is critical for maintaining cellular energy homeostasis. Understanding this mechanism clarifies how feeding and fasting cycles entrain peripheral clocks, helping explain how metabolic disruptions impair tissue clock function.
Caveats
This study is a preprint and has not yet been peer-reviewed. Additionally, the findings rely on an immortalized human cell line and theoretical modeling rather than intact animal or human physiological systems.
Written from the paper’s abstract, and every claim checked against it before publishing. Read the paper for the full methods and data.
The paper
Experimental and mathematical models reveal that AMPK modulates circadian clock gene expression and period through NAD+-dependent regulation of Bmal1
Vandenberghe A, Delpierre P, Torero-Ibad R et al.
bioRxiv · 30 Sep 2026 · Preprint, not yet peer-reviewed
- Relevance
- Relevant
- News value
- Notable
- Evidence
- Cells
- Status
- Preprint
More on NAD+ & sirtuins
See allMacrophage CD38 drives age-related placental senescence by depleting NAD+
Targeting CD38 or supplementing NAD+ precursors reduces placental aging and improves offspring metabolic health in models of delayed maternal age.
Nature communications · Hua L et al.
Activating Sirt1 reduces aortic valve calcification in mice and human cells
The sirtuin protects valves by activating the Nrf2 pathway, preserving mitochondrial function, and preventing iron-driven ferroptosis.
International journal of molecular medicine · Yan F et al.
Erigeron breviscapus extends worm lifespan and reduces senescence markers in mice
The herbal extract activates AMPK-SIRT1 signaling, enhancing antioxidant defenses and modulating apoptosis to alleviate tissue aging across both model organisms.
Biogerontology · Pu Y et al.